| Literature DB >> 29072610 |
Shaowa Lü1, Shuyu Dong2, Dan Xu3, Jixin Duan4, Guoyu Li5, Yuyan Guo6, Haixue Kuang7, Qiuhong Wang8,9.
Abstract
Caulophyllum robustum Maxim (CRM) is a Chinese folk medicine with significant effect on treatment of rheumatoid arthritis (RA). This study was designed to explore the spectrum-effect relationships between high-performance liquid chromatography (HPLC) fingerprints and the anti-inflammatory effects of CRM. Seventeen common peaks were detected by fingerprint similarity evaluation software. Among them, 15 peaks were identified by Liquid Chromatography-Mass Spectrometry (LC-MS). Pharmacodynamics experiments were conducted in collagen-induced arthritis (CIA) mice to obtain the anti-inflammatory effects of different batches of CRM with four pro-inflammation cytokines (TNF-α, IL-β, IL-6, and IL-17) as indicators. These cytokines were suppressed at different levels according to the different batches of CRM treatment. The spectrum-effect relationships between chemical fingerprints and the pro-inflammation effects of CRM were established by multiple linear regression (MLR) and gray relational analysis (GRA). The spectrum-effect relationships revealed that the alkaloids (N-methylcytisine, magnoflorine), saponins (leiyemudanoside C, leiyemudanoside D, leiyemudanoside G, leiyemudanoside B, cauloside H, leonticin D, cauloside G, cauloside D, cauloside B, cauloside C, and cauloside A), sapogenins (oleanolic acid), β-sitosterols, and unknown compounds (X3, X17) together showed anti-inflammatory efficacy. The results also showed that the correlation between saponins and inflammatory factors was significantly closer than that of alkaloids, and saponins linked with less sugar may have higher inhibition effect on pro-inflammatory cytokines in CIA mice. This work provided a general model of the combination of HPLC and anti-inflammatory effects to study the spectrum-effect relationships of CRM, which can be used to discover the active substance and to control the quality of this treatment.Entities:
Keywords: Caulophyllum robustum Maxim; collagen-induced arthritis (CIA) model; gray relational analysis (GRA); multiple linear regression (MLR); spectrum-effect relationship
Mesh:
Substances:
Year: 2017 PMID: 29072610 PMCID: PMC6150361 DOI: 10.3390/molecules22111826
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(a) HPLC fingerprint; (b) the mutual mode; and (c) mixed reference substances.
The relative retention time of 17 common peaks.
| 0.135 | 0.651 | 0.754 | 0.768 | 0.778 | 0.850 | 0.862 | 0.888 | 0.911 | |
| 0.134 | 0.650 | 0.753 | 0.767 | 0.777 | 0.849 | 0.862 | 0.888 | 0.911 | |
| 0.134 | 0.650 | 0.754 | 0.768 | 0.778 | 0.850 | 0.861 | 0.888 | 0.912 | |
| 0.133 | 0.649 | 0.752 | 0.766 | 0.777 | 0.848 | 0.860 | 0.888 | 0.911 | |
| 0.134 | 0.649 | 0.752 | 0.766 | 0.777 | 0.847 | 0.859 | 0.888 | 0.903 | |
| 0.134 | 0.648 | 0.752 | 0.766 | 0.777 | 0.848 | 0.860 | 0.888 | 0.911 | |
| 0.133 | 0.646 | 0.750 | 0.764 | 0.774 | 0.845 | 0.857 | 0.886 | 0.910 | |
| 0.132 | 0.645 | 0.749 | 0.763 | 0.774 | 0.845 | 0.859 | 0.885 | 0.909 | |
| 0.132 | 0.645 | 0.749 | 0.763 | 0.773 | 0.845 | 0.856 | 0.885 | 0.909 | |
| 0.132 | 0.645 | 0.749 | 0.763 | 0.774 | 0.845 | 0.856 | 0.885 | 0.909 | |
| 0.132 | 0.645 | 0.750 | 0.764 | 0.775 | 0.846 | 0.857 | 0.887 | 0.910 | |
| 0.133 | 0.647 | 0.751 | 0.765 | 0.776 | 0.847 | 0.795 | 0.887 | 0.910 | |
| 0.721 | 0.352 | 0.232 | 0.260 | 0.217 | 0.235 | 0.273 | 0.164 | 0.260 | |
| 0.930 | 1.000 | 1.419 | 1.446 | 1.499 | 1.614 | 1.669 | 1.800 | ||
| 0.930 | 1.000 | 1.418 | 1.445 | 1.498 | 1.614 | 1.668 | 1.799 | ||
| 0.931 | 1.000 | 1.419 | 1.445 | 1.498 | 1.614 | 1.668 | 1.800 | ||
| 0.930 | 1.000 | 1.418 | 1.445 | 1.498 | 1.614 | 1.668 | 1.799 | ||
| 0.930 | 1.000 | 1.417 | 1.443 | 1.497 | 1.612 | 1.666 | 1.797 | ||
| 0.930 | 1.000 | 1.418 | 1.444 | 1.497 | 1.613 | 1.667 | 1.799 | ||
| 0.929 | 1.000 | 1.413 | 1.439 | 1.492 | 1.607 | 1.661 | 1.792 | ||
| 0.929 | 1.000 | 1.412 | 1.438 | 1.491 | 1.606 | 1.660 | 1.791 | ||
| 0.929 | 1.000 | 1.412 | 1.438 | 1.491 | 1.606 | 1.660 | 1.791 | ||
| 0.928 | 1.000 | 1.413 | 1.439 | 1.492 | 1.607 | 1.661 | 1.792 | ||
| 0.929 | 1.000 | 1.416 | 1.442 | 1.495 | 1.611 | 1.665 | 1.796 | ||
| 0.930 | 1.000 | 1.416 | 1.443 | 1.496 | 1.611 | 1.665 | 1.796 | ||
| 0.001 | 0.000 | 0.210 | 0.219 | 0.222 | 0.215 | 0.214 | 0.210 | ||
The relative peak area of 17 common peaks.
| 9.456 | 27.201 | 1.565 | 2.515 | 0.938 | 0.943 | 0.943 | 1.181 | 0.607 | |
| 7.074 | 21.749 | 1.319 | 2.144 | 0.900 | 1.346 | 0.767 | 1.346 | 0.702 | |
| 6.824 | 13.654 | 1.684 | 1.757 | 0.961 | 1.157 | 0.879 | 1.257 | 0.533 | |
| 8.613 | 19.969 | 1.899 | 2.195 | 0.974 | 0.906 | 0.948 | 1.236 | 0.769 | |
| 4.969 | 9.526 | 1.034 | 3.895 | 0.584 | 1.501 | 0.658 | 0.771 | 1.312 | |
| 10.942 | 21.792 | 1.645 | 1.931 | 0.922 | 0.600 | 0.599 | 1.083 | 0.553 | |
| 11.652 | 18.294 | 1.930 | 1.893 | 1.157 | 0.411 | 0.463 | 1.326 | 0.803 | |
| 12.413 | 18.635 | 1.626 | 1.874 | 0.881 | 0.374 | 0.756 | 1.487 | 0.781 | |
| 13.809 | 22.756 | 1.492 | 2.207 | 1.027 | 0.443 | 0.577 | 1.290 | 0.764 | |
| 15.058 | 25.958 | 2.264 | 2.615 | 1.262 | 0.977 | 0.959 | 1.725 | 0.629 | |
| 11.053 | 23.134 | 2.245 | 2.842 | 1.350 | 0.706 | 1.265 | 1.502 | 1.003 | |
| 10.157 | 20.040 | 1.695 | 2.373 | 1.002 | 0.842 | 0.763 | 1.296 | 0.910 | |
| 29.17 | 24.75 | 20.84 | 24.89 | 19.73 | 43.43 | 33.25 | 18.14 | 0.003 | |
| 3.312 | 1.000 | 0.780 | 0.940 | 0.776 | 0.588 | 0.716 | 0.405 | ||
| 3.402 | 1.000 | 0.461 | 0.387 | 0.411 | 0.399 | 0.758 | 0.375 | ||
| 2.646 | 1.000 | 0.534 | 0.577 | 0.415 | 0.430 | 0.845 | 0.399 | ||
| 3.276 | 1.000 | 0.721 | 1.259 | 1.201 | 0.491 | 0.845 | 0.571 | ||
| 1.422 | 1.000 | 0.560 | 0.519 | 0.846 | 0.191 | 0.391 | 0.215 | ||
| 2.847 | 1.000 | 0.808 | 1.378 | 1.172 | 0.546 | 1.182 | 0.612 | ||
| 3.189 | 1.000 | 0.533 | 0.591 | 0.441 | 0.584 | 1.004 | 0.515 | ||
| 3.324 | 1.000 | 0.439 | 0.334 | 0.283 | 0.316 | 1.068 | 0.507 | ||
| 3.795 | 1.000 | 0.434 | 0.385 | 0.387 | 0.716 | 1.176 | 0.438 | ||
| 3.985 | 1.000 | 0.428 | 0.440 | 0.329 | 0.468 | 0.744 | 0.463 | ||
| 3.532 | 1.000 | 0.370 | 0.306 | 0.358 | 0.445 | 0.958 | 0.283 | ||
| 3.174 | 1.000 | 0.562 | 0.620 | 0.575 | 0.459 | 0.875 | 0.432 | ||
| 20.73 | 0.000 | 26.50 | 59.66 | 58.48 | 30.79 | 25.39 | 26.24 | ||
The fingerprint similarity evaluation data.
| Sample | S1 | S2 | S3 | S4 | S5 | S6 | S7 | S8 | S9 | S10 | S11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.000 | 0.908 | 0.980 | 0.916 | 0.968 | 0.917 | 0.942 | 0.959 | 0.964 | 0.951 | 0.948 | |
| 0.908 | 1.000 | 0.915 | 0.862 | 0.904 | 0.891 | 0.902 | 0.905 | 0.903 | 0.909 | 0.891 | |
| 0.980 | 0.915 | 1.000 | 0.928 | 0.977 | 0.933 | 0.959 | 0.967 | 0.968 | 0.954 | 0.947 | |
| 0.916 | 0.862 | 0.928 | 1.000 | 0.920 | 0.906 | 0.919 | 0.921 | 0.916 | 0.908 | 0.908 | |
| 0.968 | 0.904 | 0.977 | 0.920 | 1.000 | 0.936 | 0.971 | 0.983 | 0.974 | 0.948 | 0.944 | |
| 0.917 | 0.891 | 0.933 | 0.906 | 0.936 | 1.000 | 0.953 | 0.952 | 0.946 | 0.942 | 0.941 | |
| 0.942 | 0.902 | 0.959 | 0.919 | 0.971 | 0.953 | 1.000 | 0.982 | 0.969 | 0.941 | 0.937 | |
| 0.959 | 0.905 | 0.967 | 0.921 | 0.983 | 0.952 | 0.982 | 1.000 | 0.980 | 0.957 | 0.948 | |
| 0.964 | 0.903 | 0.968 | 0.916 | 0.974 | 0.946 | 0.969 | 0.980 | 1.000 | 0.964 | 0.950 | |
| 0.951 | 0.909 | 0.954 | 0.908 | 0.948 | 0.942 | 0.941 | 0.957 | 0.964 | 1.000 | 0.956 | |
| 0.948 | 0.891 | 0.947 | 0.908 | 0.944 | 0.941 | 0.937 | 0.948 | 0.950 | 0.956 | 1.000 | |
| 0.977 | 0.935 | 0.985 | 0.945 | 0.984 | 0.965 | 0.979 | 0.987 | 0.985 | 0.976 | 0.971 |
Figure 2The results of HCA.
Figure 3Anti-inflammatory activity index of (a) paw swelling (%); (b) swelling inhibition rate; (c) arthritis index (AI)’ and (d) body weight change.
Figure 4The levels of pro-inflammatory cytokines: (a) TNF-α content; (b) IL-1β content; (c) IL-6 content; and (d) IL-17 content. ##: p < 0.01 was significant difference between vehicle group and the control group; *: p < 0.05 was considered statistically significant between vehicle group and treatment groups; ** : p < 0.01 was significant difference between vehicle group and treatment groups.
Multiple comparison SNK test results of TNF-α(a: Alpha).
| The Content of TNF-α | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group | N | Student for Alpha = 0.05 | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | |||
| Student-Newman-Keuls a | 6 | 58.78 | ||||||
| 6 | 73.80 | |||||||
| 6 | 76.54 | |||||||
| 6 | 78.18 | |||||||
| 6 | 78.34 | |||||||
| 6 | 78.93 | |||||||
| 6 | 83.45 | |||||||
| 6 | 83.91 | |||||||
| 6 | 84.09 | |||||||
| 6 | 84.42 | |||||||
| 6 | 87.51 | |||||||
| 6 | 88.19 | |||||||
| 6 | 118.67 | |||||||
| 1.00 | 1.00 | 0.107 | 0.783 | 0.510 | 1.00 | |||
Multiple comparison SNK test results of IL-1β.
| The Content of IL-1β | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Group | N | Student for Alpha = 0.05 | ||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| Student-Newman-Keuls a | 6 | 43.39 | ||||||||
| 6 | 50.32 | |||||||||
| 6 | 53.61 | |||||||||
| 6 | 60.11 | |||||||||
| 6 | 63.65 | |||||||||
| 6 | 82.40 | |||||||||
| 6 | 82.62 | |||||||||
| 6 | 83.32 | |||||||||
| 6 | 83.59 | |||||||||
| 6 | 83.99 | 83.99 | ||||||||
| 6 | 85.95 | |||||||||
| 6 | 85.99 | |||||||||
| 6 | 120.49 | |||||||||
| 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 0.395 | 0.072 | 1.00 | |||
Multiple comparison SNK test results of IL-6.
| The Content of IL-6 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Group | N | Student for Alpha = 0.05 | ||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| Student-Newman-Keuls a | 6 | 92.34 | ||||||||
| 6 | 103.01 | |||||||||
| 6 | 104.89 | 104.89 | ||||||||
| 6 | 106.37 | 106.37 | 106.37 | |||||||
| 6 | 109.40 | 109.40 | 109.40 | 109.40 | ||||||
| 6 | 112.13 | 112.13 | 112.13 | 112.13 | 112.13 | |||||
| 6 | 112.43 | 112.43 | 112.43 | 112.43 | 112.43 | |||||
| 6 | 113.97 | 113.97 | 113.97 | 113.97 | 113.97 | |||||
| 6 | 115.68 | 115.68 | 115.68 | 115.68 | ||||||
| 6 | 117.42 | 117.42 | 117.42 | |||||||
| 6 | 120.36 | 120.36 | ||||||||
| 6 | 122.37 | |||||||||
| 6 | 152.93 | |||||||||
| 1.000 | 0.055 | 0.071 | 0.060 | 0.148 | 0.130 | 0.085 | 1.00 | |||
Multiple comparison SNK test results of IL-17.
| The Content of IL-17 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Group | N | Student for Alpha = 0.05 | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | |||
| Student-Newman-Keuls a | 6 | 75.15 | ||||||
| 6 | 86.52 | |||||||
| 6 | 90.33 | 90.33 | ||||||
| 6 | 91.75 | 91.75 | ||||||
| 6 | 91.83 | 91.83 | ||||||
| 6 | 92.93 | 92.93 | ||||||
| 6 | 94.10 | 94.10 | 94.10 | |||||
| 6 | 97.64 | 97.64 | 97.64 | |||||
| 6 | 99.20 | 99.20 | 99.20 | |||||
| 6 | 102.14 | 102.14 | ||||||
| 6 | 104.01 | |||||||
| 6 | 105.63 | |||||||
| 6 | 129.14 | |||||||
| 1.000 | 0.165 | 0.084 | 0.059 | 0.092 | 1.00 | |||
Figure 5Pearson correlation coefficients between the peak area and inflammatory markers, (a) TNF-α; (b) IL-1β; (c) IL-6; and (d) IL-17.
Integration of the analytical results.
| Correlation Analysis | TNF-α | IL-1β | IL-6 | IL-17 |
|---|---|---|---|---|
| STEPWISE MLR | X2, X6 | X1, X3, X6 | X1, X13 | X1, X2, X10, X15 |
| PCA | X2, X11, X17 | X1, X6, X7, X12, X13, X14 | X2, X17 | X1, X2, X7, X10, X15 |
| in total | X2, X6, X11, X17 | X1, X3, X6, X7, X12, X13, X14 | X1, X2, X13, X17 | X1, X2, X7, X10, X15 |
The results of GRA between 17 characteristic peaks and sera cytokines.
| TNF-α | IL-1β | IL-6 | IL-17 | |||||
|---|---|---|---|---|---|---|---|---|
| No. | Correlation | No. | Correlation | No. | Correlation | No. | Correlation | |
| 1 | X17 | 0.7878 | X17 | 0.7214 | X8 | 0.9528 | X17 | 0.9221 |
| 2 | X15 | 0.7861 | X15 | 0.7199 | X5 | 0.9506 | X15 | 0.9188 |
| 3 | X12 | 0.7811 | X12 | 0.7144 | X11 | 0.9498 | X12 | 0.9135 |
| 4 | X14 | 0.7783 | X14 | 0.7105 | X7 | 0.9497 | X14 | 0.9094 |
| 5 | X13 | 0.7775 | X13 | 0.7100 | X3 | 0.9476 | X13 | 0.9075 |
| 6 | X9 | 0.7685 | X9 | 0.7042 | X16 | 0.9451 | X9 | 0.8979 |
| 7 | X7 | 0.7680 | X16 | 0.7035 | X6 | 0.9439 | X7 | 0.8958 |
| 8 | X16 | 0.7668 | X7 | 0.7031 | X13 | 0.9420 | X16 | 0.8940 |
| 9 | X6 | 0.7633 | X5 | 0.6980 | X12 | 0.9414 | X6 | 0.8896 |
| 10 | X5 | 0.7607 | X6 | 0.6971 | X14 | 0.9397 | X5 | 0.8858 |
| 11 | X11 | 0.7569 | X11 | 0.6939 | X9 | 0.9395 | X11 | 0.8813 |
| 12 | X8 | 0.7480 | X8 | 0.6873 | X4 | 0.9372 | X8 | 0.8686 |
| 13 | X3 | 0.7328 | X3 | 0.6736 | X15 | 0.9359 | X3 | 0.8477 |
| 14 | X4 | 0.7082 | X4 | 0.6505 | X17 | 0.9317 | X4 | 0.8172 |
| 15 | X10 | 0.6881 | X10 | 0.6355 | X10 | 0.9030 | X10 | 0.7886 |
| 16 | X1 | 0.5820 | X1 | 0.5445 | X1 | 0.7286 | X1 | 0.6531 |
| 17 | X2 | 0.5227 | X2 | 0.4894 | X2 | 0.6380 | X2 | 0.5789 |
Assignments of the correlated peaks.
| No. | Mass Data | Compound | Aglycones | Formula | Mol. Wt. | |
|---|---|---|---|---|---|---|
| X1 | [M + H]+ | 205.1 | - | C12H16N2O | 204 | |
| X2 | [M + H]+ | 343.2 | Magnoflorine | - | C20H24NO4 | 342 |
| X3 | [M + H]+ | 344.1 | Unknown | - | - | 343 |
| X4 | [M − H]− | 1559.7 | Leyemudanoside D | Caulophyllogenin | C71H116O37 | 1560 |
| X5 | [M − H]− | 1251.6 | Leyemudanoside C | Caulophyllogenin | C59H96O28 | 1252 |
| X6 | [M + Na]+ | 1111.5 | Leyemudanoside G | 11-oxo-Hederagenin | C53H84O23 | 1088 |
| X7 | [M − H]− | 1251.6 | Leyemudanoside B | Caulophyllogenin | C59H96O28 | 1252 |
| X8 | [M − H]− | 1251.2 | Cauloside H | Caulophyllogenin | C59H96O28 | 1252 |
| X9 | [M − H]− | 1089.0 | Leonticin D | Caulophyllogenin | C53H86O23 | 1090 |
| X10 | [M − H]− | 1235.2 | Cauloside G | Hederagenin | C59H96O27 | 1236 |
| X11 | [M − H]− | 1073.0 | Cauloside D | Hederagenin | C53H86O22 | 1074 |
| X12 | [M − H]− | 618.91 | Cauloside B | Caulophyllogenin | C35H56O9 | 620 |
| X13 | [M − H]− | 765.07 | Cauloside C | Hederagenin | C41H66O13 | 766 |
| X14 | [M − H]− | 603.3 | Cauloside A | Hederagenin | C35H56O8 | 604 |
| X15 | [M − H]− | 455.3 | Oleanic acid | - | C30H48O3 | 456 |
| X16 | [M − CH3]− | 399 | β-sitosterol | - | C29H50O | 414 |
| X17 | [M − H]− | 749.1 | Unknown | - | - | 750 |
The CRM samples with their different harvest times and habitats.
| Sample No. | Collection Time | Origin |
|---|---|---|
| September 2013 | Dazhou mountain in Sichuan Province, China | |
| September 2013 | Dazhou mountain in Sichuan Province, China | |
| September 2014 | Mao county in Sichuan Province, China | |
| August 2014 | Mao county in Sichuan Province, China | |
| September 2014 | Anguo city in Hebei Province, China | |
| September 2014 | Anguo city in Hebei Province, China | |
| September 2014 | Suiling Zhangjiawan forest farm in Heilongjiang Province, China | |
| September 2014 | Suiling Zhangjiawan forest farm in Heilongjiang Province, China | |
| September 2013 | Suiling Zhangjiawan forest farm in Heilongjiang Province, China | |
| September 2013 | Suiling Zhangjiawan forest farm in Heilongjiang Province, China | |
| September 2012 | Suiling Zhangjiawan forest farm in Heilongjiang Province, China |